Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients
Gururaj Rao Deshpande1, Gajanan N Sapkal1, Bipin N Tilekar1, Pragya D Yadav2, Yogesh Gurav3, Shivshankar Gaikwad1, Himanshu Kaushal4, Ketki S Deshpande1, Ojas Kaduskar1, Prasad Sarkale2, Srikant Baradkar2, Annasaheb Suryawanshi2, Rajen Lakra2, AP Sugunan5, Anukumar Balakrishnan5, Priya Abraham1, Pavan Salve6
1 Diagnostic Virology Group, Pimpri Chinchwad Municipal Corporation, Pune, Maharashtra, India 2 Maximum Containment Facility, ICMR-National Institute of Virology, Pune, Maharashtra, India 3 Epidemiology Group, ICMR-National Institute of Virology, Pune, Maharashtra, India 4 Influenza Group, ICMR-National Institute of Virology, Pune, Maharashtra, India 5 ICMR-National Institute of Virology, Kerala Unit, Alappuzha, Kerala, India 6 Medical Department, Pimpri Chinchwad Municipal Corporation, Pune, Maharashtra, India
Correspondence Address:
Gajanan N Sapkal Sapkal, Diagnostic Virology Group, ICMR-National Institute of Virology, Sus Road, Pashan, Pune 411 021, Maharashtra India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijmr.IJMR_2382_20
|